These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19242505)

  • 1. Preventive and therapeutic effects of imatinib in Wistar-Kyoto rats with anti-glomerular basement membrane glomerulonephritis.
    Iyoda M; Shibata T; Kawaguchi M; Yamaoka T; Akizawa T
    Kidney Int; 2009 May; 75(10):1060-70. PubMed ID: 19242505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long- and short-term treatment with imatinib attenuates the development of chronic kidney disease in experimental anti-glomerular basement membrane nephritis.
    Iyoda M; Shibata T; Wada Y; Kuno Y; Shindo-Hirai Y; Matsumoto K; Akizawa T
    Nephrol Dial Transplant; 2013 Mar; 28(3):576-84. PubMed ID: 23045430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-4 ameliorates crescentic glomerulonephritis in Wistar Kyoto rats.
    Cook HT; Singh SJ; Wembridge DE; Smith J; Tam FW; Pusey CD
    Kidney Int; 1999 Apr; 55(4):1319-26. PubMed ID: 10200996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with a cyclin-dependent kinase inhibitor, seliciclib, is effective in reducing glomerular macrophage numbers and the severity of established experimental glomerulonephritis.
    Sheryanna AM; Smith J; Bhangal G; Barnett A; McClue S; Tam FW; Cook T; Pusey CD
    Nephrology (Carlton); 2011 May; 16(4):410-6. PubMed ID: 21518118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis.
    Khan SB; Cook HT; Bhangal G; Smith J; Tam FW; Pusey CD
    Kidney Int; 2005 May; 67(5):1812-20. PubMed ID: 15840028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Important role for macrophages in induction of crescentic anti-GBM glomerulonephritis in WKY rats.
    Isome M; Fujinaka H; Adhikary LP; Kovalenko P; El-Shemi AG; Yoshida Y; Yaoita E; Takeishi T; Takeya M; Naito M; Suzuki H; Yamamoto T
    Nephrol Dial Transplant; 2004 Dec; 19(12):2997-3004. PubMed ID: 15574997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice.
    Sadanaga A; Nakashima H; Masutani K; Miyake K; Shimizu S; Igawa T; Sugiyama N; Niiro H; Hirakata H; Harada M
    Arthritis Rheum; 2005 Dec; 52(12):3987-96. PubMed ID: 16320345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of anti-glomerular basement membrane nephritis in rats by ONO-1301, a non-prostanoid prostaglandin I2 mimetic compound with inhibitory activity against thromboxane A2 synthase.
    Hayashi K; Nagamatsu T; Oka T; Suzuki Y
    Jpn J Pharmacol; 1997 Jan; 73(1):73-82. PubMed ID: 9032136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
    Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
    J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with an antibody to VLA-1 integrin reduces glomerular and tubulointerstitial scarring in a rat model of crescentic glomerulonephritis.
    Cook HT; Khan SB; Allen A; Bhangal G; Smith J; Lobb RR; Pusey CD
    Am J Pathol; 2002 Oct; 161(4):1265-72. PubMed ID: 12368200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANG II receptor blockade enhances anti-inflammatory macrophages in anti-glomerular basement membrane glomerulonephritis.
    Aki K; Shimizu A; Masuda Y; Kuwahara N; Arai T; Ishikawa A; Fujita E; Mii A; Natori Y; Fukunaga Y; Fukuda Y
    Am J Physiol Renal Physiol; 2010 Apr; 298(4):F870-82. PubMed ID: 20071465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of experimental crescentic glomerulonephritis by interleukin-10 gene transfer.
    El-Shemi AG; Fujinaka H; Matsuki A; Kamiie J; Kovalenko P; Qu Z; Bilim V; Nishimoto G; Yaoita E; Yoshida Y; Anegon I; Yamamoto T
    Kidney Int; 2004 Apr; 65(4):1280-9. PubMed ID: 15086467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats.
    Chen YM; Ng YY; Lin SL; Chiang WC; Lan HY; Tsai TJ
    Nephrol Dial Transplant; 2004 May; 19(5):1106-15. PubMed ID: 14993492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine kinases inhibition by Imatinib slows progression in chronic anti-thy1 glomerulosclerosis of the rat.
    Wang-Rosenke Y; Khadzhynov D; Loof T; Mika A; Kawachi H; Neumayer HH; Peters H
    BMC Nephrol; 2013 Oct; 14():223. PubMed ID: 24119229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAK-603, an anti-inflammatory compound, reduces crescentic glomerulonephritis and preserves renal function in WKY rats.
    Yamahana J; Wada T; Furuichi K; Sakai N; Yokoyama H; Kaneko S
    Nephrol Dial Transplant; 2006 Oct; 21(10):2736-44. PubMed ID: 16891648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imatinib attenuates end-organ damage in hypertensive homozygous TGR(mRen2)27 rats.
    Schellings MW; Baumann M; van Leeuwen RE; Duisters RF; Janssen SH; Schroen B; Peutz-Kootstra CJ; Heymans S; Pinto YM
    Hypertension; 2006 Mar; 47(3):467-74. PubMed ID: 16432052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imatinib ameliorates renal disease and survival in murine lupus autoimmune disease.
    Zoja C; Corna D; Rottoli D; Zanchi C; Abbate M; Remuzzi G
    Kidney Int; 2006 Jul; 70(1):97-103. PubMed ID: 16688113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose local kidney irradiation inhibits progression of experimental crescentic nephritis by promoting apoptosis.
    Liu D; Nazneen A; Taguchi T; Razzaque MS
    Am J Nephrol; 2008; 28(4):555-68. PubMed ID: 18239382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of human mesenchymal stem cells in Wistar-Kyoto rats with anti-glomerular basement membrane glomerulonephritis.
    Suzuki T; Iyoda M; Shibata T; Ohtaki H; Matsumoto K; Shindo-Hirai Y; Kuno Y; Wada Y; Yamamoto Y; Kawaguchi M; Shioda S; Akizawa T
    PLoS One; 2013; 8(6):e67475. PubMed ID: 23826305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Butein ameliorates experimental anti-glomerular basement membrane (GBM) antibody-associated glomerulonephritis in rats (1).
    Hayashi K; Nagamatsu T; Honda S; Suzuki Y
    Jpn J Pharmacol; 1996 Jan; 70(1):55-64. PubMed ID: 8822089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.